Evidence map›Paper›PMID 42428516›Full record

ArticleNeuro-oncology advances

Peritumoral brain zone oxygen extraction fraction is associated with tumor Ki-67 index in untreated glioblastoma.

Jonas Reis, Marco Öchsner, Antonia Neubauer, Chiara Adam, Louisa von Baumgarten, Darius Kalasauskas, Florian Ringel, Thomas Liebig, Nathalie L Albert, Patrick N Harter and 1 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jonas ReisInstitute of Neuroradiology, LMU University Hospital, LMU Munich, Germany.ORCID https://orcid.org/0000-0001-8932-2265
Marco ÖchsnerInstitute of Neuroradiology, LMU University Hospital, LMU Munich, Germany.
Antonia NeubauerCenter for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Germany.
Chiara AdamInstitute of Neuroradiology, LMU University Hospital, LMU Munich, Germany.
Louisa von BaumgartenDepartment of Neurology, LMU University Hospital, LMU Munich, Germany.ORCID https://orcid.org/0000-0002-6634-0927
Darius KalasauskasDepartment of Neurosurgery, LMU University Hospital, LMU Munich, Germany.
Florian RingelDepartment of Neurosurgery, LMU University Hospital, LMU Munich, Germany.
Thomas LiebigInstitute of Neuroradiology, LMU University Hospital, LMU Munich, Germany.
Nathalie L AlbertDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Germany.
Patrick N HarterCenter for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Germany.
Robert ForbrigInstitute of Neuroradiology, LMU University Hospital, LMU Munich, Germany.ORCID https://orcid.org/0000-0002-1054-1463

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The non-contrast-enhancing peritumoral brain zone (PBZ) contributes to glioblastoma progression but remains incompletely characterized by structural MRI. We tested whether PBZ oxygen extraction fraction (OEF) derived from dynamic susceptibility contrast (DSC) MRI is associated with the Ki‑67 proliferation index at the patient level. Methods: In this retrospective analysis, we analyzed 80 adults with untreated Results: PBZ OEF demonstrated a positive correlation with Ki-67 (Spearman ρ = 0.27, Conclusions: Higher DSC-derived PBZ OEF ratio was modestly but significantly associated with higher tumor Ki-67 in untreated

Indexed as

contrast MRIdynamic susceptibilityglioblastomaKi-67oxygen extraction fractionperitumoral brain zone

Identifiers

PMID42428516
PMCPMC13348716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.